{
  "Variants Include": [
    {
      "Gene": "PARK7",
      "variants": [
        {
          "HGVS": "NM_001130800.3:c.310G>A",
          "cDNA Change": {
            "transcript": "NM_001130800.3",
            "ref": "G",
            "alt": "A",
            "position": "310"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "104"
          },
          "Description in input context": "A104T mutation associated with structural changes in the protein"
        },
        {
          "HGVS": "NM_001130800.3:c.430A>G",
          "cDNA Change": {
            "transcript": "NM_001130800.3",
            "ref": "A",
            "alt": "G",
            "position": "430"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "144"
          },
          "Description in input context": "E163K mutation affecting salt bridge formation"
        },
        {
          "HGVS": "NM_001130800.3:c.154A>T",
          "cDNA Change": {
            "transcript": "NM_001130800.3",
            "ref": "A",
            "alt": "T",
            "position": "154"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "L",
            "position": "52"
          },
          "Description in input context": "M26I mutation disrupting protein stability"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Familial Parkinsonism",
    "MONDO": "MONDO:0005318"
  },
  "Experiment Method": [
    {
      "Assay Method": "X-ray Crystallography",
      "Material used": {
        "Material Source": "Protein samples",
        "Material Name": "Recombinant PARK7 protein",
        "Description": "Structural analysis of PARK7 variants using recombinant protein"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001130800.3:c.310G>A",
          "Conclusion": "Structural disruption",
          "Molecular Effect": "Introduction of water molecule and disordered residue",
          "Result Description": "A104T mutation shows altered hydrogen bonding and conformational changes"
        },
        {
          "Variant": "NM_001130800.3:c.430A>G",
          "Conclusion": "Structural disruption",
          "Molecular Effect": "Disruption of salt bridge between E163 and K144",
          "Result Description": "E163K mutation leads to destabilization of the protein core"
        },
        {
          "Variant": "NM_001130800.3:c.154A>T",
          "Conclusion": "Structural disruption",
          "Molecular Effect": "Reduced hydrophobic interactions at M26",
          "Result Description": "M26I mutation decreases protein stability and folding efficiency"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Biochemical Analysis of Engineered Substitutions",
      "Material used": {
        "Material Source": "Mutant and wild-type constructs",
        "Material Name": "PARK7 variants (M26L, A104V, E163K/R145E)",
        "Description": "Analysis of engineered substitutions to validate functional effects"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001130800.3:c.154A>T",
          "Conclusion": "Functional disruption",
          "Molecular Effect": "Reduced protein stability",
          "Result Description": "M26L substitution showed decreased enzymatic activity"
        },
        {
          "Variant": "NM_001130800.3:c.310G>A",
          "Conclusion": "Functional disruption",
          "Molecular Effect": "Altered substrate binding",
          "Result Description": "A104V mutation disrupted ligand interaction"
        },
        {
          "Variant": "NM_001130800.3:c.430A>G",
          "Conclusion": "Functional disruption",
          "Molecular Effect": "Impaired protein-protein interactions",
          "Result Description": "E163K/R145E double mutant showed reduced dimerization"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}